The impact of opioid prescription dose and duration during a Workers Compensation claim, on post-claim continued opioid use: A retrospective population-based study
Background Workers Compensation Board (WCB) recipients are a group commonly prescribed opioids. Methods We explored factors influencing post‐claim opioid dose and duration by linking data from 22,451 claims with the Manitoba Center for Population Health registry. Results On average, the WCB paid for...
Saved in:
Published in | American journal of industrial medicine Vol. 58; no. 6; pp. 650 - 657 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.06.2015
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
Workers Compensation Board (WCB) recipients are a group commonly prescribed opioids.
Methods
We explored factors influencing post‐claim opioid dose and duration by linking data from 22,451 claims with the Manitoba Center for Population Health registry.
Results
On average, the WCB paid for 94.55% of opioids prescribed during a claim. The amount paid for by the WCB varied significantly by total opioids prescribed. The main predictors of high opioid dosage (120 + morphine equivalents (ME)/day) during the first year post‐claim (logistic regression), and of longer post‐claim opioid usage (survival analysis), included opioid dosage during the final month of the claim both paid for and not paid for by the WCB.
Conclusions
Amongst low dose opioid claims, the WCB covers most opioids prescribed. Higher opioid dose WCB recipients are often prescribed opioids not covered by the WCB. Both opioids paid for and not paid for by the WCB are associated with post‐claim opioid use. Am. J. Ind. Med. 58:650–657, 2015. © 2015 Wiley Periodicals, Inc. |
---|---|
Bibliography: | ArticleID:AJIM22453 istex:1DE286963234AE1F2AF7C081AFAFB69ADB033EC3 ark:/67375/WNG-MF9PZ6QF-K ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0271-3586 1097-0274 |
DOI: | 10.1002/ajim.22453 |